Cargando…

PPARs at the crossroads of T cell differentiation and type 1 diabetes

T-cell-mediated autoimmune type 1 diabetes (T1D) is characterized by the immune-mediated destruction of pancreatic beta cells (β-cells). The increasing prevalence of T1D poses significant challenges to the healthcare system, particularly in countries with struggling economies. This review paper high...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riaz, Farooq, Wei, Ping, Pan, Fan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623333/ https://www.ncbi.nlm.nih.gov/pubmed/37928539 http://dx.doi.org/10.3389/fimmu.2023.1292238

Ejemplares similares

Tolerogenic Dendritic Cells and T-Regulatory Cells at the Clinical Trials Crossroad for the Treatment of Autoimmune Disease; Emphasis on Type 1 Diabetes Therapy
por: Phillips, Brett Eugene, et al.
Publicado: (2019)

Aryl hydrocarbon receptor: The master regulator of immune responses in allergic diseases
por: Riaz, Farooq, et al.
Publicado: (2022)

Type 1 Diabetes at a Crossroads!
por: Cefalu, William T., et al.
Publicado: (2015)

Targeting post-translational modifications of Foxp3: a new paradigm for regulatory T cell-specific therapy
por: Riaz, Farooq, et al.
Publicado: (2023)

Crossroads between Bacterial and Mammalian Glycosyltransferases
por: Brockhausen, Inka
Publicado: (2014)

Genes at the Crossroad of Primary Immunodeficiencies and Cancer
por: Derpoorter, Charlotte, et al.
Publicado: (2018)

Crossroads of Cancer and HIV-1: Pathways to a Cure for HIV
por: Gavegnano, Christina, et al.
Publicado: (2019)

JAK/STAT Cytokine Signaling at the Crossroad of NK Cell Development and Maturation
por: Gotthardt, Dagmar, et al.
Publicado: (2019)

The podocyte: glomerular sentinel at the crossroads of innate and adaptive immunity
por: Burke, George W., et al.
Publicado: (2023)

Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
por: Castro, Flávia, et al.
Publicado: (2018)

Editorial: Mitochondria at the Crossroads of Immunity and Inflammatory Tissue Damage
por: Nunes, João Paulo Silva, et al.
Publicado: (2021)

ATP-dependent transporters: emerging players at the crossroads of immunity and metabolism
por: Balasubramanian, Akshaya, et al.
Publicado: (2023)

Editorial: Venoms and Toxins: At the Crossroads of Basic, Applied and Clinical Immunology
por: Pucca, Manuela B., et al.
Publicado: (2021)

Eicosapentaenoic acid-rich oil supplementation activates PPAR-γ and delays skin wound healing in type 1 diabetic mice
por: Burger, Beatriz, et al.
Publicado: (2023)

Editorial: Iron Metabolism at the Crossroad of Innate Immune Response and Cancer Progression
por: Zacchi, Paola, et al.
Publicado: (2022)

Genomic crossroads between non-Hodgkin’s lymphoma and common variable immunodeficiency
por: Guevara-Hoyer, Kissy, et al.
Publicado: (2022)

Single-Nucleotide Polymorphism of PPARγ, a Protein at the Crossroads of Physiological and Pathological Processes
por: Petrosino, Maria, et al.
Publicado: (2017)

Lipopolysaccharide Recognition in the Crossroads of TLR4 and Caspase-4/11 Mediated Inflammatory Pathways
por: Zamyatina, Alla, et al.
Publicado: (2020)

DICER1: A Key Player in Rheumatoid Arthritis, at the Crossroads of Cellular Stress, Innate Immunity, and Chronic Inflammation in Aging
por: De Cauwer, Aurore, et al.
Publicado: (2018)

PPARs and the Development of Type 1 Diabetes
por: Holm, Laurits J., et al.
Publicado: (2020)

Corrigendum: Lipopolysaccharide Recognition in the Crossroads of TLR4 and Caspase-4/11 Mediated Inflammatory Pathways
por: Zamyatina, Alla, et al.
Publicado: (2021)

Common crossroads in diabetes management
por: Valitutto, Michael
Publicado: (2008)

Body mass index at the crossroads of osteoporosis and type 2 diabetes
por: Ha, Jeonghoon, et al.
Publicado: (2020)

Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation
por: Pellegrini, Carolina, et al.
Publicado: (2017)

Parsing the Role of PPARs in Macrophage Processes
por: Toobian, Daniel, et al.
Publicado: (2021)

Chemokines in Type 1 Diabetes Mellitus
por: Pan, Xiongfeng, et al.
Publicado: (2022)

Immunomodulatory effects of microbiota-derived metabolites at the crossroad of neurodegenerative diseases and viral infection: network-based bioinformatics insights
por: Onisiforou, Anna, et al.
Publicado: (2022)

Fine-tuning of regulatory T cells is indispensable for the metabolic steatosis-related hepatocellular carcinoma: A review
por: Riaz, Farooq, et al.
Publicado: (2022)

Hematopoietic Stem Cells in Type 1 Diabetes
por: Pastore, Ida, et al.
Publicado: (2021)

Crossroads : English, 1
por: Haines, Philip
Publicado: (2006)

Di-(2-ethylhexyl) Phthalate Promotes Allergic Lung Inflammation by Modulating CD8α(+) Dendritic Cell Differentiation via Metabolite MEHP-PPARγ Axis
por: Tseng, Hsin-Han, et al.
Publicado: (2022)

Enhanced T Cell Glucose Uptake Is Associated With Progression of Beta-Cell Function in Type 1 Diabetes
por: Tang, Rong, et al.
Publicado: (2022)

Crossroad
por: Paz-Pacheco, Elizabeth
Publicado: (2022)

Differential regulation of Type 1 and Type 2 mouse eosinophil activation by apoptotic cells
por: Dolitzky, Avishay, et al.
Publicado: (2022)

Modulation of Gut Microbiota by Low Methoxyl Pectin Attenuates Type 1 Diabetes in Non-obese Diabetic Mice
por: Wu, Chengfei, et al.
Publicado: (2019)

Regulatory B Cells: Role in Type 1 Diabetes
por: Boldison, Joanne, et al.
Publicado: (2021)

Inflammasomes and Type 1 Diabetes
por: Pearson, James Alexander, et al.
Publicado: (2021)

HIV-1 Nef: at the crossroads
por: Foster, John L, et al.
Publicado: (2008)

Dendritic Cell Subsets in Type 1 Diabetes: Friend or Foe?
por: Morel, Penelope A.
Publicado: (2013)

Therapies to Suppress β Cell Autoimmunity in Type 1 Diabetes
por: Kroger, Charles J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_u95i24t437gcfbqmgo3du2p4cg